Pavlina Zatloukalova

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA.

Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA.

Journal: Bioscience reports

Published: June 04, 2025

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation.

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation.

Journal: Molecular oncology

Published: March 31, 2025

Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.

Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.

Journal: BMC cancer

Published: November 19, 2024

Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.

Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.

Journal: Cellular & molecular biology letters

Published: April 09, 2024

Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Journal: Cellular & molecular biology letters

Published: August 04, 2021

Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody.

Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody.

Journal: The Biochemical journal

Published: September 04, 2020

The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276.

The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276.

Journal: Cellular & molecular biology letters

Published: April 04, 2020

Anticancer pentamethinium salt is a potent photosensitizer inducing mitochondrial disintegration and apoptosis upon red light illumination.

Anticancer pentamethinium salt is a potent photosensitizer inducing mitochondrial disintegration and apoptosis upon red light illumination.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: March 12, 2020

CRISPR-Cas9 as a Tool in Cancer Therapy.

CRISPR-Cas9 as a Tool in Cancer Therapy.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: October 20, 2019

A Cyclic Pentamethinium Salt Induces Cancer Cell Cytotoxicity through Mitochondrial Disintegration and Metabolic Collapse.

A Cyclic Pentamethinium Salt Induces Cancer Cell Cytotoxicity through Mitochondrial Disintegration and Metabolic Collapse.

Journal: International journal of molecular sciences

Published: July 12, 2019

Prima-1 and APR-246 in Cancer Therapy.

Prima-1 and APR-246 in Cancer Therapy.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: January 01, 2018

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: November 17, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026